BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34284042)

  • 1. Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission.
    Nuwer JL; Brady ML; Povysheva NV; Coyne A; Jacob TC
    Neuropharmacology; 2021 Oct; 197():108724. PubMed ID: 34284042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term α5 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition.
    Nuwer JL; Povysheva N; Jacob TC
    Neuropharmacology; 2023 Oct; 237():109587. PubMed ID: 37270156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depolarizing, inhibitory GABA type A receptor activity regulates GABAergic synapse plasticity via ERK and BDNF signaling.
    Brady ML; Pilli J; Lorenz-Guertin JM; Das S; Moon CE; Graff N; Jacob TC
    Neuropharmacology; 2018 Jan; 128():324-339. PubMed ID: 29074304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of extra-synaptic α5-GABA
    Etherington LA; Mihalik B; Pálvölgyi A; Ling I; Pallagi K; Kertész S; Varga P; Gunn BG; Brown AR; Livesey MR; Monteiro O; Belelli D; Barkóczy J; Spedding M; Gacsályi I; Antoni FA; Lambert JJ
    Neuropharmacology; 2017 Oct; 125():353-364. PubMed ID: 28807671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of α5 subunit-containing γ-aminobutyric acid type A receptors: implications for treating cognitive deficits.
    Manzo MA; Wang DS; Li WW; Pinguelo A; Popa MO; Khodaei S; Atack JR; Ross RA; Orser BA
    Br J Anaesth; 2021 Mar; 126(3):674-683. PubMed ID: 33388140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Input-Specific Synaptic Location and Function of the α5 GABA
    Magnin E; Francavilla R; Amalyan S; Gervais E; David LS; Luo X; Topolnik L
    J Neurosci; 2019 Jan; 39(5):788-801. PubMed ID: 30523065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct regulation of tonic GABAergic inhibition by NMDA receptor subtypes.
    Wu K; Castellano D; Tian Q; Lu W
    Cell Rep; 2021 Nov; 37(6):109960. PubMed ID: 34758303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the Selective α5-GABAAR Antagonist S44819 on Excitability in the Human Brain: A TMS-EMG and TMS-EEG Phase I Study.
    Darmani G; Zipser CM; Böhmer GM; Deschet K; Müller-Dahlhaus F; Belardinelli P; Schwab M; Ziemann U
    J Neurosci; 2016 Dec; 36(49):12312-12320. PubMed ID: 27927951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors.
    Jacob TC
    Front Mol Neurosci; 2019; 12():179. PubMed ID: 31396049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms.
    Xue JG; Masuoka T; Gong XD; Chen KS; Yanagawa Y; Law SK; Konishi S
    J Neurophysiol; 2011 Jun; 105(6):2897-906. PubMed ID: 21471392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Guanidine-4-methylquinazoline acts as a novel competitive antagonist of A type γ-aminobutyric acid receptors.
    Xiao X; Zhu MX; Xu TL
    Neuropharmacology; 2013 Dec; 75():126-37. PubMed ID: 23916476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome.
    Schulz JM; Knoflach F; Hernandez MC; Bischofberger J
    J Neurosci; 2019 Jun; 39(26):5210-5221. PubMed ID: 31000585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic localization of α5 GABA (A) receptors via gephyrin interaction regulates dendritic outgrowth and spine maturation.
    Brady ML; Jacob TC
    Dev Neurobiol; 2015 Nov; 75(11):1241-51. PubMed ID: 25663431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Inhibitory Synaptic Plasticity Enhances Tonic Current by Increasing the Content of α5-Subunit Containing GABA
    Wyroślak M; Lebida K; Mozrzymas JW
    Neuroscience; 2021 Jul; 467():39-46. PubMed ID: 34033868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of dendritic tonic GABAergic inhibition regulates excitability and plasticity in CA1 pyramidal neurons.
    Groen MR; Paulsen O; Pérez-Garci E; Nevian T; Wortel J; Dekker MP; Mansvelder HD; van Ooyen A; Meredith RM
    J Neurophysiol; 2014 Jul; 112(2):287-99. PubMed ID: 24760781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors.
    Fischell J; Van Dyke AM; Kvarta MD; LeGates TA; Thompson SM
    Neuropsychopharmacology; 2015 Oct; 40(11):2499-509. PubMed ID: 25900119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear α5-GABA
    Schulz JM; Knoflach F; Hernandez MC; Bischofberger J
    Nat Commun; 2018 Sep; 9(1):3576. PubMed ID: 30177704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.
    Zanos P; Nelson ME; Highland JN; Krimmel SR; Georgiou P; Gould TD; Thompson SM
    eNeuro; 2017; 4(1):. PubMed ID: 28275719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA is a modulator, rather than a classical transmitter, in the medial nucleus of the trapezoid body-lateral superior olive sound localization circuit.
    Fischer AU; Müller NIC; Deller T; Del Turco D; Fisch JO; Griesemer D; Kattler K; Maraslioglu A; Roemer V; Xu-Friedman MA; Walter J; Friauf E
    J Physiol; 2019 Apr; 597(8):2269-2295. PubMed ID: 30776090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin Reduces Cortical GABAergic Transmission and Alleviates MK-801-Induced Hyperactivity.
    Fan HR; Du WF; Zhu T; Wu YJ; Liu YM; Wang Q; Wang Q; Gu X; Shan X; Deng S; Zhu T; Xu TL; Ge WH; Li WG; Li F
    EBioMedicine; 2018 Aug; 34():201-213. PubMed ID: 30057312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.